Supplementary Table S12 from TPP-45142—an Anti-HER2 T-cell Engager—Designed for Selective HER2-Low Cancer Immunotherapy
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Supplementary Table S12 shows mean pharmacokinetic parameters of TPP-45131 in a non-clinical exploratory NHP study (n = 2)
Fields of Study & Subjects
Monoclonal and Polyclonal Antibodies Research
HER2/EGFR in Cancer Research
Cancer Immunotherapy and Biomarkers
Publication details
- Publication date
- 2 April 2026
- Language
- EN